Multiple Myeloma News and Research

RSS
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
Study finds barriers to stem cell transplant use among multiple myeloma patients from minority groups

Study finds barriers to stem cell transplant use among multiple myeloma patients from minority groups

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Mayo Clinic researchers find emojis to be helpful in assessing patients' quality of life

Mayo Clinic researchers find emojis to be helpful in assessing patients' quality of life

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Two immunotherapy approaches for multiple myeloma show hope

Two immunotherapy approaches for multiple myeloma show hope

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Study unveils new immunotherapeutic target against multiple myeloma

Study unveils new immunotherapeutic target against multiple myeloma

New technique holds promise to screen cancer cells for drug susceptibility

New technique holds promise to screen cancer cells for drug susceptibility

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

Cancers linked to obesity account for 40% of all cancers in the US, report states

Cancers linked to obesity account for 40% of all cancers in the US, report states

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Categories of Preference included for recommendations within NCCN Guidelines

Categories of Preference included for recommendations within NCCN Guidelines

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA